The Global Pharmaceutical Industry and China’s Position

Mei-ling Wang

Chapter 3 in WTO, Globalization and China’s Health Care System, 2007, pp 55-85 from Palgrave Macmillan

Abstract: Abstract Discussions of China’s pharmaceutical industry in the WTO framework cannot be separated from an analysis of the global pharmaceutical industry. The global pharmaceutical industry has never played a more important role than it does today in addressing the mortality and morbidity of global populations, given the threatening increase of global pandemics and emergent health issues, such as HIV/AIDS, avian flu, SARS, TB, hepatitis and debilitating chronic diseases (cancer, diabetes, Alzheimer’s disease and so on). Global developments will inevitably have an impact on the position of the Chinese pharmaceutical industry as China is integrated into the global market by the WTO. The purpose of this chapter is to examine prospects for the global pharmaceutical industry, China’s pharmaceutical industry and its position in the global market, and the major benefits and challenges facing China’s pharmaceutical sector.

Keywords: Chinese Government; Good Manufacture Practice; Intellectual Property Right; Pharmaceutical Market; Pharmaceutical Consumption (search for similar items in EconPapers)
Date: 2007
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-28696-2_3

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230286962

DOI: 10.1057/9780230286962_3

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().